The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data

Table 2 Median patient survival, and median EPO and IV iron given for the total study duration

	Median	Interquartile range (25%)	Interquartile range (75%)
Survival duration (days)	789	354	1489
EPO administered per week (10³ units)	18.16	12.1	27.74
IV iron administered per month (mg)	301.2	201.6	454.7

ISSN: 1471-2369